The Library

Commentary : controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease

Tools

Cappuccio, Francesco. (2008) Commentary : controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease. BMJ, Vol.336 . pp. 1248-1249. ISSN 0959-535X

Preview

PDF
WRAP_Cappuccio_0482983-061008-BMJ_2008_NICE_lipids.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (249Kb)

Official URL: http://dx.doi.org/10.1136/bmj.39580.424352.AD

Abstract

The new guidelines from the National Institute for Health and Clinical Excellence (NICE) on lipid modification for the prevention of cardiovascular disease will guide the way we assess cardiovascular risk and treat lipids, both in primary and in secondary care. What are the new aspects, and what is it that might spark controversy in this new publication?

Item Type:

Journal Article

Subjects:

R Medicine > R Medicine (General)

Divisions:

Faculty of Medicine > Warwick Medical School

Library of Congress Subject Headings (LCSH):

National Institute for Clinical Excellence (Great Britain), Cardiovascular system -- Diseases

Journal or Publication Title:

BMJ

Publisher:

BMJ Publishing Group Ltd.

ISSN:

0959-535X

Official Date:

31 May 2008

Dates:

Date	Event
31 May 2008	Published

Volume:

Vol.336

Page Range:

pp. 1248-1249

Identification Number:

10.1136/bmj.39580.424352.AD

Status:

Peer Reviewed

Publication Status:

Published

Access rights to Published version:

Open Access

References:

1 Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM. Application of
Framingham risk estimates to ethnic minorities in the UK and
implications for primary prevention in general practice: a cross
sectional population based study. BMJ 2002;325:1271-4.
2 BrindleP,MayM,GillP,CappuccioFP,D’AgostinoRSr, FischbacherC,
et al. Primary prevention of cardiovascular disease: a web-based risk
score for seven British black and minority ethnic groups. Heart
2006;92:1595-602.
3 LittleP,Kelly J,Barnett J,DorwardM,MargettsB,WarmD.Randomised
controlled factorial trialofdietaryadvicefor patientswithasinglehigh
blood pressure reading in primary care. BMJ 2004;328:1054-7.
4 World Health Organization. Reducing salt intake in populations:
report of a WHO forum and technical meeting. Geneva: WHO,
2007:1-60.
5 Cappuccio FP. Salt and cardiovascular disease. BMJ
2007;334:859-60.
6 Sever PS,Dahlöf B, Poulter NR,Wedel H, Beevers G, Caulfield M, et al.
Prevention of coronary and stroke events with atorvastatin in
hypertensive patients who have average or lower-than-average
cholesterol concentrations, in the Anglo-Scandinavian Cardiac
Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre
randomized controlled trial. Lancet 2003;361:1149-58.
7 British Cardiac Society, British Hypertension Society, Diabetes UK,
HEART UK, Primary Care Cardiovascular Society, Stroke Association.
JBS 2: Joint British Societies’ guidelines on prevention of
cardiovascular disease in clinical practice. Heart
2005;91(suppl 5):v1-52.
8 WilliamsB, PoulterNR,BrownMJ, DavisM,McInnes GT,Potter JF, et al.
Guidelines for management of hypertension: report of the fourth
working party of theBritish HypertensionSociety, 2004-BHSIV.JHum
Hypertens 2004;18:139-85.